ASH 2023 | Challenges for community clinicians treating multiple myeloma
Luciano Costa, MD, PhD, UAB School of Medicine, Birmingham, AL, highlights challenges for community clinicians when treating multiple myeloma (MM). He underscores the complexity of advanced therapies like CAR-T and bispecifics, advocating for their administration in specialized hospital settings. Dr Costa emphasizes the crucial role of communication between academic and community physicians for proper referrals to myeloma specialists and smooth transitions to the community setting post-treatment. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Adaptive biotechnologies: Consultancy, Honoraria; Amgen: Consultancy, Honoraria, Research Funding; Genentech: Research Funding; AbbVie: Honoraria, Research Funding; Janssen: Consultancy, Honoraria, Research Funding; Pfizer: Consultancy, Honoraria; BMS: Consultancy, Honoraria, Research Funding.
